Chemoinformaics analysis of meso-Dihydroguaiaretic acid
| Molecular Weight | 330.424 | nRot | 7 |
| Heavy Atom Molecular Weight | 304.216 | nRig | 12 |
| Exact Molecular Weight | 330.183 | nRing | 2 |
| Solubility: LogS | -4.676 | nHRing | 0 |
| Solubility: LogP | 3.998 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
| nHA | 4 | APOL | 53.9446 |
| nHD | 2 | BPOL | 29.5554 |
| QED | 0.8 |
| Synth | 2.864 |
| Natural Product Likeliness | 0.573 |
| NR-PPAR-gamma | 0.063 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.414 |
| Pgp-sub | 0.238 |
| HIA | 0.004 |
| CACO-2 | -4.713 |
| MDCK | 0.0000164 |
| BBB | 0.062 |
| PPB | 0.98814 |
| VDSS | 1.108 |
| FU | 0.0079932 |
| CYP1A2-inh | 0.753 |
| CYP1A2-sub | 0.963 |
| CYP2c19-inh | 0.924 |
| CYP2c19-sub | 0.801 |
| CYP2c9-inh | 0.886 |
| CYP2c9-sub | 0.934 |
| CYP2d6-inh | 0.875 |
| CYP2d6-sub | 0.934 |
| CYP3a4-inh | 0.721 |
| CYP3a4-sub | 0.827 |
| CL | 15.138 |
| T12 | 0.82 |
| hERG | 0.074 |
| Ames | 0.072 |
| ROA | 0.055 |
| SkinSen | 0.92 |
| Carcinogencity | 0.14 |
| EI | 0.871 |
| Respiratory | 0.478 |
| NR-Aromatase | 0.626 |
| Antiviral | No |
| Prediction | 0.75894 |